Indraprastha Historical Cash Flow

INDRAMEDCO   436.85  0.55  0.13%   
Analysis of Indraprastha Medical cash flow over time is an excellent tool to project Indraprastha Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 1.4 B or Change In Working Capital of 582.3 M as it is a great indicator of Indraprastha Medical ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Indraprastha Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Indraprastha Medical is a good buy for the upcoming year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indraprastha Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Indraprastha Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Indraprastha balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Indraprastha's non-liquid assets can be easily converted into cash.

Indraprastha Medical Cash Flow Chart

At present, Indraprastha Medical's Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 1.4 B, whereas Depreciation is forecasted to decline to about 300.3 M.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Indraprastha Medical to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Indraprastha Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Indraprastha Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Indraprastha Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indraprastha Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, Indraprastha Medical's Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 1.4 B, whereas Depreciation is forecasted to decline to about 300.3 M.
 2021 2022 2023 2024 (projected)
Capital Expenditures294.8M445.8M693.9M379.6M
Dividends Paid2.6M228.4M275.4M176.4M

Indraprastha Medical cash flow statement Correlations

0.230.260.230.350.36-0.27-0.040.140.350.190.41-0.11-0.28-0.31
0.230.580.260.620.53-0.430.120.560.760.54-0.060.12-0.25-0.41
0.260.580.830.880.56-0.70.580.940.870.250.010.170.18-0.93
0.230.260.830.70.29-0.420.590.640.640.2-0.180.010.4-0.82
0.350.620.880.70.63-0.620.580.850.980.370.24-0.01-0.06-0.92
0.360.530.560.290.63-0.540.520.560.650.430.32-0.33-0.21-0.52
-0.27-0.43-0.7-0.42-0.62-0.54-0.25-0.74-0.62-0.16-0.410.14-0.090.63
-0.040.120.580.590.580.52-0.250.640.510.060.080.090.16-0.68
0.140.560.940.640.850.56-0.740.640.840.180.170.280.07-0.9
0.350.760.870.640.980.65-0.620.510.840.440.190.03-0.11-0.87
0.190.540.250.20.370.43-0.160.060.180.440.24-0.16-0.6-0.23
0.41-0.060.01-0.180.240.32-0.410.080.170.190.24-0.19-0.64-0.23
-0.110.120.170.01-0.01-0.330.140.090.280.03-0.16-0.19-0.13-0.13
-0.28-0.250.180.4-0.06-0.21-0.090.160.07-0.11-0.6-0.64-0.13-0.07
-0.31-0.41-0.93-0.82-0.92-0.520.63-0.68-0.9-0.87-0.23-0.23-0.13-0.07
Click cells to compare fundamentals

Indraprastha Medical Account Relationship Matchups

Indraprastha Medical cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory(37.5M)33.3M(12.5M)15.4M9.2M9.7M
Change In Cash35.1M45.9M168.2M105.2M93.4M98.1M
Free Cash Flow455.3M69.4M418.1M998.9M1.3B1.4B
Change In Working Capital155.0M(11.9M)(264.6M)66.6M554.6M582.3M
Begin Period Cash Flow168.2M203.3M249.2M417.4M522.6M548.7M
Other Cashflows From Financing Activities(38.8M)(29.0M)(31.1M)(32M)(48.4M)(46.0M)
Depreciation329.7M333.2M349.4M392.7M400.8M300.3M
Other Non Cash Items(102.1M)(85.3M)(162.6M)(186.4M)(193.5M)(203.2M)
Dividends Paid178.6M2.5M2.6M228.4M275.4M176.4M
Capital Expenditures409.2M209.6M294.8M445.8M693.9M379.6M
Total Cash From Operating Activities864.5M279.0M712.9M1.4B2.0B2.1B
Net Income481.9M42.9M790.7M1.2B1.2B1.3B
Total Cash From Financing Activities(427.4M)(31.5M)(33.7M)(260.4M)(323.8M)(340.0M)
End Period Cash Flow203.3M249.2M417.4M522.6M616M646.8M
Change To Account Receivables27.6M85.3M259.5M(234.9M)138.7M145.6M
Net Borrowings(260M)(228.5M)(20.9M)(25.1M)(28.9M)(30.3M)
Total Cashflows From Investing Activities(401.9M)(201.6M)(511M)(1.1B)(971.2M)(922.6M)
Other Cashflows From Investing Activities7.3M8.0M24.8M(633.3M)(570.0M)(541.5M)
Change To Netincome37.3M(56.4M)(65.7M)41.9M37.7M39.6M
Change To Liabilities(318.1M)41.4M165.0M(141.2M)(281.5M)0.0
Investments(401.9M)(201.6M)(241M)(1.1B)(1.6B)(1.5B)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Indraprastha Stock

The Cash Flow Statement is a financial statement that shows how changes in Indraprastha balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Indraprastha's non-liquid assets can be easily converted into cash.